Latest Aquaculture Sector News

Seafarms Group has completed the acquisition of Project Sea Dragon's assets, clearing legal hurdles and advancing its prawn farming operations while actively pursuing new funding to support growth.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Vitrafy Life Sciences has secured a 12-month exclusive partnership with global animal reproduction leader IMV Technologies to co-develop and commercialise next-generation cryopreservation solutions for farm animals and aquaculture.

BPH Global Ltd has reported a record-breaking month in its Indonesian seaweed operations, more than doubling previous sales and advancing its export capabilities.

Seafarms Group Limited has resumed trading on the ASX following the lifting of its suspension, triggered by the lodgement of its annual financial report.

BPH Global Ltd reports steady seaweed sales of A$222,656 for August, supported by a fully operational warehouse in Makassar and ongoing partnerships in Indonesia.

BPH Global Limited reported a strong 161.7% revenue increase to nearly $288,000 for FY25, driven by new seaweed operations in Indonesia, yet the company remains in the red with a $1.3 million net loss. The firm continues to raise capital and integrate acquisitions as it charts a path forward.

BPH Global Ltd reports a robust 50.9% increase in seaweed sales for July 2025, driven by strong domestic demand in Indonesia and plans to expand internationally.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Carnegie Clean Energy has made significant strides in advancing its wave energy technologies, signing key MOUs and achieving critical milestones in the ACHIEVE Programme during the June 2025 quarter.

Sprintex has advanced a promising trial with a major Dutch agribusiness, potentially unlocking €4.8 million in sales, while also securing a significant private-label contract in China’s booming aquaculture sector.

Vitrafy Life Sciences reported robust progress in Q4 FY2025, advancing its cryopreservation technology and commercial partnerships while preparing for a pivotal product launch in FY2026.